SCHEMBL7369990

SCHEMBL7369990

Cc1cc(CN)nn1Cc1cccc(C#N)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.46
CYP11B1 P15538 1/20 0.46
CYP11B2 P19099 1/20 0.46
KLKB1 P03952 1/20 0.46
KLK1 P06870 1/20 0.46
ALDH1A1 P00352 2/20 0.45
BRD4 O60885 1/20 0.45
KMT2A Q03164 1/20 0.41
DRD4 P21917 2/20 0.40
DRD3 P35462 2/20 0.40
DRD2 P14416 1/20 0.40
TSHR P16473 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
ADORA2A P29274 1/20 0.40
ADORA2B P29275 1/20 0.40
ADORA1 P30542 1/20 0.40
MAPT P10636 1/20 0.39
CREBBP Q92793 1/20 0.39
IDH1 O75874 1/20 0.39
GLA P06280 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7368765 0.86 CYP19A1 (0.46) CYP19A1CYP11B1CYP11B2KLKB1KLK1
SCHEMBL7373944 0.80 PTGER1 (0.47) CYP19A1CYP11B1CYP11B2KLKB1KLK1
SCHEMBL7375052 0.77 CYP19A1 (0.50) CYP19A1CYP11B1CYP11B2KLKB1KLK1
SCHEMBL16832399 0.76 KDM4E (0.62) CYP19A1CYP11B1CYP11B2KLKB1KLK1
SCHEMBL580840 0.72 LOXL2 (0.61) CYP19A1CYP11B1CYP11B2KLKB1KLK1
SCHEMBL30358086 0.72 LOXL2 (0.61) CYP19A1CYP11B1CYP11B2KLKB1KLK1
Water SCHEMBL5709133 0.72 LOXL2 (0.61) CYP19A1CYP11B1CYP11B2KLKB1KLK1
Hydrochloric Acid SCHEMBL2326110 0.70 LOXL2 (0.59) CYP19A1CYP11B1CYP11B2KLKB1KLK1
Bromide SCHEMBL6433668 0.70 LOXL2 (0.59) CYP19A1CYP11B1CYP11B2KLKB1KLK1
SCHEMBL7234546 0.70 CCR2 (0.51) CYP19A1CYP11B1CYP11B2KLKB1KLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002000651-A2 FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2002-01-03 WO disclosed